跨国药企碰瓷失败,百济神州专利保卫战大捷

药渡
01 May

2025年4月29日,美国专利商标局(简称“USPTO”)作出了一项最终书面决定,宣布艾伯维旗下的Pharmacyclics公司在803专利授权后复审(简称“PGR”)程序中受到质疑的803专利的全部权利无效。对于百济神州来说,这是一个好消息。在2023年6月13日,Pharmacyclics公司作为申诉方,在美国特拉华州地方法院,对百济神州及其全资子公司BeOne Medicines USA提出...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10